دورية أكاديمية
Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines.
| العنوان: | Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines. |
|---|---|
| المؤلفون: | Malundo AFG; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Taft Avenue, Ermita, Manila, National Capital Region, Philippines., Abad CLR; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Salamat MSS; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Sandejas JCM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Poblete JB; Department of Medicine, University of the Philippines - Philippine General Hospital, Manila, Philippines., Planta JEG; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Morales SJL; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Gabunada RRW; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Evasan ALM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines., Cañal JPA; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Santos JA; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Manto JT; Department of Radiology, University of the Philippines - Philippine General Hospital, Manila, Philippines., Mercado MEP; Department of Clinical Epidemiology, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines., Rojo RD; College of Medicine, University of the Philippines, Manila, Philippines., Ornos EDB; College of Medicine, University of the Philippines, Manila, Philippines., Alejandria MM; Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines. |
| المصدر: | IJID regions [IJID Reg] 2022 Sep; Vol. 4, pp. 134-142. Date of Electronic Publication: 2022 Jul 14. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918418183106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-7076 (Electronic) Linking ISSN: 27727076 NLM ISO Abbreviation: IJID Reg Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Amsterdam] : Elsevier Ltd., [2021]- |
| مستخلص: | Objectives: The aim of this study was to determine the predictors of mortality and describe laboratory trends among adults with confirmed COVID-19. Methods: The medical records of adult patients admitted to a referral hospital with COVID-19 were retrospectively reviewed. Demographic and clinical characteristics, and laboratory parameters, were compared between survivors and non-survivors. Predictors of mortality were determined by multivariate analysis. Mean laboratory values were plotted across illness duration. Results: Of 1215 patients, 203 (16.7%) had mild, 488 (40.2%) moderate, 183 (15.1%) severe, and 341 (28.1%) critical COVID-19 on admission. In-hospital mortality was 18.2% (0% mild, 6.1% moderate, 15.8% severe, 47.5% critical). Predictors of mortality were age ≥ 60 years, COPD, qSOFA score ≥ 2, WBC > 10 × 10 9 /L, absolute lymphocyte count < 1000, neutrophil ≥ 70%, PaO Conclusion: The overall mortality rate was high. Predictors of mortality were similar to those of other reports globally. Marked inflammation and worsening pulmonary and renal function were evident among non-survivors by the 2nd-3rd week of illness. Competing Interests: The authors declare no conflicts of interest. (© 2022 The Author(s).) |
| References: | Cardiovasc Res. 2020 Dec 1;116(14):2197-2206. (PMID: 33063089) PLoS One. 2020 Nov 3;15(11):e0241742. (PMID: 33141836) BMJ Evid Based Med. 2021 Jun;26(3):107-108. (PMID: 32934000) World J Urol. 2021 Aug;39(8):2987-2993. (PMID: 33481113) J Med Virol. 2021 Jan;93(1):250-256. (PMID: 32592501) Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. (PMID: 32286245) Int Immunopharmacol. 2021 Jun;95:107586. (PMID: 33765611) J Gen Intern Med. 2021 Jan;36(1):17-26. (PMID: 32607928) Ann Intern Med. 2021 Jan;174(1):33-41. (PMID: 32960645) Am J Trop Med Hyg. 2021 Nov 17;106(1):142-149. (PMID: 34788739) Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. (PMID: 32798471) Crit Care. 2020 Jul 2;24(1):389. (PMID: 32616077) N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530) Trop Med Health. 2020 Jun 22;48(1):51. (PMID: 34686216) PLoS One. 2021 Jul 29;16(7):e0255154. (PMID: 34324560) BMC Infect Dis. 2021 Jul 8;21(1):663. (PMID: 34238232) J Neural Transm (Vienna). 2021 Nov;128(11):1687-1703. (PMID: 34448930) Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076) Br J Pharmacol. 2020 Oct;177(19):4375-4385. (PMID: 32698249) J Bras Nefrol. 2021 Jul-Sep;43(3):383-399. (PMID: 33836039) BMJ. 2021 Mar 9;372:n579. (PMID: 33687922) Clin Epidemiol Glob Health. 2021 Apr-Jun;10:100695. (PMID: 33490719) Ren Fail. 2021 Dec;43(1):1621-1633. (PMID: 34882508) Sci Rep. 2020 Nov 26;10(1):20731. (PMID: 33244144) Nat Med. 2021 Feb;27(2):264-269. (PMID: 33311702) J Korean Med Sci. 2020 Aug 03;35(30):e280. (PMID: 32743995) Sci Rep. 2021 Feb 12;11(1):3735. (PMID: 33580190) PLoS One. 2020 Nov 17;15(11):e0241955. (PMID: 33201896) |
| فهرسة مساهمة: | Keywords: COVID-19; Philippines; epidemiology; mortality |
| تواريخ الأحداث: | Date Created: 20220720 Latest Revision: 20220731 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC9281405 |
| DOI: | 10.1016/j.ijregi.2022.07.009 |
| PMID: | 35854825 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder كن أول من يترك تعليقا!